UBC researcher closing in on chlamydia vaccine

Through its Proof-of-Concept (POC) program, Genome B.C. is funding the necessary pre-clinical studies to move a novel chlamydia vaccine to human trials. Robert Brunham, professor of Infectious Diseases at UBC and Provincial Executive Director of the B.C. Centre for Disease Control, is leading the POC project titled “Accelerating the Development of a Novel Outer Membrane Protein Based Vaccine Against Chlamydia Infection”. In partnership with the Canadian not-for-profit Pan-Provincial Vaccine Enterprise Inc., the project is expected to run over the next 21 months and will include U.S. Food and Drug Administration filings for anticipated clinical grade vaccine production. For more information, click here.